Track: Business and Medical devices research on Diabetes

Diabetes 2026

Session Overview

This session provides an overview of the latest innovations in diabetes medical devices and the business strategies driving their adoption. It explores how technology is improving patient monitoring, insulin delivery, and data-driven care. The session also discusses the challenges of regulatory approval, cost, and accessibility, and highlights the role of partnerships between clinicians, researchers, and industry.


Key Topics

Continuous Glucose Monitoring (CGM) Systems: CGM devices provide real-time glucose readings and trend data, enabling better glycemic control and reducing the risk of complications through timely intervention.


Insulin Pumps and Smart Pens: Insulin pumps and smart pens offer precise insulin delivery and dosing support, improving convenience and reducing errors in insulin administration.


Wearable Sensors and Digital Health: Wearable sensors and digital health platforms integrate data from glucose monitoring, physical activity, and diet to provide personalized diabetes management insights.


Regulatory and Market Trends: Understanding regulatory pathways, reimbursement policies, and market demand is essential for successful device development and commercialization.


Investment and Commercialization Strategies: This topic covers funding opportunities, startup growth strategies, and partnerships needed to bring innovative diabetes devices to market.


Learning Objectives

The session aims to enhance knowledge of market dynamics, regulatory requirements, and commercialization strategies. Attendees will learn how digital health and wearable technologies are transforming diabetes management. The session also highlights opportunities for collaboration between clinicians, researchers, and industry to bring innovative solutions to patients.